lymphoma
BostonGene Helping MassGeneral Improve Understanding of Follicular Lymphoma Progression, Treatment
The company will analyze tumor genetics and microenvironments to advance research into why some follicular lymphomas become aggressive and treatment response.
Epizyme Partnering With Quest Diagnostics for Lymphoma Mutation Testing
The companies have launched an initiative to improve patient access to EZH2 mutation testing for patients with relapsed or refractory follicular lymphoma.
Barbara Ann Karmanos Cancer Institute Receives $325K Lymphoma Research Grant
The grant will fund a pilot study measuring circulating tumor DNA to help identify patients likely to relapse after autologous stem cell transplantation.
NCI researchers performed a multi-platform study to elucidate the factors that can contribute to a patient's better-than-expected response to a drug.
The Swiss-American bioinformatics company touts its networks of multimodal data and numerous partnerships as it looks to support "data-driven medicine."